![]() |
市場調查報告書
商品編碼
1637689
歐洲放射腫瘤學市場預測至 2031 年 - 區域分析 - 按類型和應用Europe Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application |
2023年歐洲放射腫瘤市值為33.1721億美元,預計2031年將達到87.2307億美元;預計2023年至2031年複合年成長率為12.8%。
支持放射腫瘤學發展的措施推動歐洲放射腫瘤學市場
各國政府和組織正在引入利用放射療法快速有效治療癌症的使命和計劃。 2023年9月,國際原子能總署(IAEA)宣布了「希望之光」旗艦癌症計劃,旨在發展放射治療基礎設施。在美國、德國、英國、法國等已開發國家,幾乎所有患者都能接受放射治療。在中等收入國家,60% 的患者群體和低收入國家十分之一的患者能夠接受放射治療。 「人人享有希望之光癌症照護」重點關注全世界放射治療服務的發展。自該計劃啟動以來,各國都收到了放射治療設備以及操作設備以進行及時診斷和治療所需的培訓。五大洲都參與了該計劃,並為該計劃捐款 4,550 萬美元(4,200 萬歐元),私營部門投資了 768,902 美元(710,000 歐元)提供支持。此外,醫科達等製造商與國際原子能機構簽署了合作夥伴關係,透過在世界各地提供放射治療設備來改善癌症治療。此外,原子能機構開始培訓不同領域的醫療保健專業人員,其中包括14名放射腫瘤學家、13名醫學物理學家、4名核子醫學技術專家、7名核子醫學醫師、7名放射性藥劑師、16名放射治療技術專家、7名腫瘤護理師、4名醫學影像技術專家和7名放射科醫師。因此,放射治療措施的激增預計將提高低收入國家的滲透率,加上訓練有素的專業人員和放射治療基礎設施的發展正在推動未來幾年放射腫瘤學市場的成長。
歐洲放射腫瘤學市場概況
德國擁有先進的醫療基礎設施,可以使用支援放射治療程序實施的尖端技術。該國也以其對創新和研究的高度重視而聞名。在德國營運的綜合癌症中心提供多學科治療計劃,包括放射治療、手術、化療和其他醫療程序。 2020 年,瓦里安宣布位於海德堡的德國癌症研究中心 (DKFZ) 訂購了自適應智慧解決方案,這是該國首個 Ethos 療法。這種由人工智慧驅動的全方位解決方案旨在提高放射治療的療效、適應性和能力。
歐洲放射腫瘤學市場收入及 2031 年預測(百萬美元)
歐洲放射腫瘤學市場細分
歐洲放射腫瘤學市場按類型、應用和國家分類。
根據類型,歐洲放射腫瘤學市場分為體外放射治療和內照射放射治療。 2023 年,體外放射治療領域將佔據更大的市場佔有率。
從應用來看,歐洲放射腫瘤市場分為乳癌、攝護腺癌、肺癌、頭頸癌、子宮頸癌等。 2023 年,乳癌細分市場佔據最大的市場佔有率。
依國家/地區分類,歐洲放射腫瘤市場分為德國、英國、法國、西班牙、義大利和歐洲其他地區。 2023 年,德國在歐洲放射腫瘤市場佔有率中佔據主導地位。
Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Nordion、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc 和 Curium 是歐洲輻射領域的一些領先公司腫瘤學市場。
The Europe radiation oncology market was valued at US$ 3,317.21 million in 2023 and is expected to reach US$ 8,723.07 million by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031.
Initiatives to Support Developments in Radiation Oncology Drive Europe Radiation Oncology Market
The governments and organizations are introducing missions and programs for the quick and effective treatment of cancer with the use of radiotherapy. In September 2023, the International Atomic Energy Agency (IAEA) announced the "Rays of Hope"-flagship cancer initiative for the development of radiotherapy infrastructure. In developed countries such as the US, Germany, UK, France, and others nearly all patients have access to radiotherapy. In middle-income countries 60% of the patient population and 1 in 10 patients in low-income countries have access to radiotherapy. The "Rays of Hope Cancer Care for All" focuses on the development of radiotherapy services all over the world. Since, launch of the initiative, various countries have received radiotherapy equipment and training required to operate the equipment for timely diagnosis and treatment. All the five continents are involved in the initiative and contributed US$ 45.5 million (Euro 42 million) for the initiative and the private sector invested US$ 768,902 (Euro 710,000) for support. Moreover, manufacturers such as Elekta signed a partnership with IAEA for the improvement of cancer treatment by providing radiotherapy equipment around the world. Additionally, IAEA started training healthcare professionals from different field this includes 14 radiation oncologist, 13 medical physicist, 4 nuclear medicine technologist, 7 nuclear medicine physician, 7 radiopharmacist, 16 radiation therapy technologist, 7 oncology nurses, 4 medical imaging technologist, and 7 radiologists. Therefore, surging initiatives for radiotherapy is expected to increase the penetration in low-income countries along with trained professionals and development in radiotherapy infrastructure is driving the growth of radiation oncology market in coming years.
Europe Radiation Oncology Market Overview
Germany has an advanced healthcare infrastructure with access to cutting-edge technologies that support the implementation of radiotherapy procedures. The country is also renowned for its strong emphasis on innovation and research. Comprehensive cancer centers operating in Germany provide multidisciplinary treatment plans incorporating radiation therapy, surgery, chemotherapy, and other medical procedures. In 2020, Varian announced that the German Cancer Research Center (DKFZ) in Heidelberg ordered an Adaptive Intelligence solution, the first Ethos therapy in the country. This AI-powered, all-encompassing solution aims to improve the efficacy, adaptability, and capacity of radiotherapy.
Europe Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)
Europe Radiation Oncology Market Segmentation
The Europe radiation oncology market is categorized into types, application, and country.
Based on type, the Europe radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.
In terms of application, the Europe radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.
By country, the Europe radiation oncology market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe radiation oncology market share in 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, and Curium are some of the leading companies operating in the Europe radiation oncology market.